secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K/A
Filed at:   2023-04-24T23:59:59+00:00
Accession:  0000950170-23-014119
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus discloses COO Craig Millian's separation terms: $445,630 severance over 12 months
--------------------------------------------------------------------------------

- Craig Millian resigned as COO; separation date April 14, 2023; agreement signed April 24, 2023.
- Severance includes $445,630 aggregate payment over 12 months plus COBRA premium reimbursement for 12 months.
- If a Change in Control occurs within 3 months of separation, severance extends to 18 months of base salary + COBRA.
- Stock option exercise period extended to 18 months from separation date.
- Agreement includes general release, cooperation, and non-disclosure obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017023014119/0000950170-23-014119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017023014119/crbp-20230303.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-014119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer